Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01241708
Title Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma ((Mel/MelVel))
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hackensack University Medical Center
Indications

multiple myeloma

Therapies

Bortezomib

Age Groups: adult
Covered Countries USA


No variant requirements are available.